Literature DB >> 9306608

Experimental replacement of the thoracic inferior vena cava with a high-porosity expanded polytetrafluoroethylene graft wrapped in an omental pedicle flap.

H Ohkashiwa1, T Nishibe, S Ohtake, K Miyazaki, H Manase, S Watanabe, T Takahashi, Y Okuda, T Tanabe, H Katoh.   

Abstract

We examined the patency and healing of a high-porosity expanded polytetrafluoroethylene (ePTFE) graft implanted as an interposition graft in the thoracic inferior vena cava (IVC) and wrapped in an omental pedicle flap. High-porosity ePTFE grafts of 60 microns fibril length, with an internal diameter of 10 mm and a length of 4 cm, were implanted in 12 mongrel dogs. In 6 dogs, the grafts were wrapped in omental pedicle flap, and in the remaining 6 the grafts were unwrapped. The animals were killed 4 weeks after the replacement and the grafts were removed for examination. Patency of the graft in both groups was 100%; however, the thrombus-free area in the omentum-wrapped group was significantly larger (P < 0.05) than that in the unwrapped group. Light microscopy revealed the marked infiltration of cells and capillaries within the graft interstices in the omentum-wrapped group. These findings suggest that encapsulation of the high-porosity ePTFE graft is promoted by an omental pedicle flap.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306608     DOI: 10.1007/BF02385276

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.540


  13 in total

Review 1.  Graft endothelialization: the role of angiogenic mechanisms.

Authors:  A W Clowes; T Kohler
Journal:  J Vasc Surg       Date:  1991-05       Impact factor: 4.268

2.  Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity.

Authors:  M A Golden; S R Hanson; T R Kirkman; P A Schneider; A W Clowes
Journal:  J Vasc Surg       Date:  1990-06       Impact factor: 4.268

3.  Early endothelial coverage of synthetic arterial grafts: porosity revisited.

Authors:  A W Clowes; R K Zacharias; T R Kirkman
Journal:  Am J Surg       Date:  1987-05       Impact factor: 2.565

4.  Angiogenic factor: a possible mechanism for neovascularization produced by omental pedicles.

Authors:  R Cartier; I Brunette; K Hashimoto; W M Bourne; H V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  1990-02       Impact factor: 5.209

5.  High porosity PTFE improves endothelialization of arterial grafts without increasing early thrombogenicity.

Authors:  B L Cameron; H Tsuchida; T P Connall; T Nagae; K Furukawa; S E Wilson
Journal:  J Cardiovasc Surg (Torino)       Date:  1993-08       Impact factor: 1.888

6.  Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.

Authors:  P G Dartevelle; A R Chapelier; U Pastorino; P Corbi; B Lenot; J Cerrina; E A Bavoux; J M Verley; J Y Neveux
Journal:  J Thorac Cardiovasc Surg       Date:  1991-08       Impact factor: 5.209

7.  Superior vena cava and central venous reconstruction.

Authors:  W M Moore; L H Hollier; T K Pickett
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

8.  Reconstruction of large veins for nonmalignant venous occlusive disease.

Authors:  P Gloviczki; P C Pairolero; B J Toomey; T C Bower; T W Rooke; A W Stanson; J W Hallett; K J Cherry
Journal:  J Vasc Surg       Date:  1992-11       Impact factor: 4.268

9.  Cellular origin and rate of endothelial cell coverage of PTFE grafts.

Authors:  D A Bull; G C Hunter; H Holubec; M L Aguirre; W D Rappaport; C W Putnam
Journal:  J Surg Res       Date:  1995-01       Impact factor: 2.192

10.  Conventional versus high-porosity polytetrafluoroethylene grafts: clinical evaluation.

Authors:  T R Kohler; J R Stratton; T R Kirkman; K H Johansen; B K Zierler; A W Clowes
Journal:  Surgery       Date:  1992-11       Impact factor: 3.982

View more
  1 in total

1.  High-porosity expanded polytetrafluoroethylene grafts for thoracic vena cava replacement with or without an omentum wrap.

Authors:  T Nishibe; K Yasuda; H Ohkashiwa; S Watanabe; Y Okuda; T Tanabe
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.